2013 Q2 Form 10-Q Financial Statement

#000115752313003978 Filed on August 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $80.93M $74.57M
YoY Change 8.52% 22.66%
Cost Of Revenue $27.21M $26.25M
YoY Change 3.66% 14.08%
Gross Profit $53.72M $48.32M
YoY Change 11.18% 27.9%
Gross Profit Margin 66.38% 64.8%
Selling, General & Admin $33.20M $30.62M
YoY Change 8.45% 48.4%
% of Gross Profit 61.81% 63.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.310M $2.710M
YoY Change 22.14% 20.44%
% of Gross Profit 6.16% 5.61%
Operating Expenses $33.20M $30.62M
YoY Change 8.45% 48.4%
Operating Profit $17.20M $14.96M
YoY Change 15.01% 0.15%
Interest Expense $88.00K -$30.00K
YoY Change -393.33% -200.0%
% of Operating Profit 0.51% -0.2%
Other Income/Expense, Net
YoY Change
Pretax Income $17.29M $14.96M
YoY Change 15.6% 0.15%
Income Tax $6.543M $5.717M
% Of Pretax Income 37.84% 38.22%
Net Earnings $10.75M $9.241M
YoY Change 16.33% 2.95%
Net Earnings / Revenue 13.28% 12.39%
Basic Earnings Per Share $0.61 $0.52
Diluted Earnings Per Share $0.60 $0.51
COMMON SHARES
Basic Shares Outstanding 17.65M shares 17.91M shares
Diluted Shares Outstanding 17.84M shares 18.15M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $128.1M $116.7M
YoY Change 9.77% 23.49%
Cash & Equivalents $128.1M $116.7M
Short-Term Investments
Other Short-Term Assets $9.100M $10.10M
YoY Change -9.9% 53.03%
Inventory
Prepaid Expenses $4.725M $4.923M
Receivables $8.023M $8.763M
Other Receivables $0.00 $1.700M
Total Short-Term Assets $145.3M $137.4M
YoY Change 5.73% 23.01%
LONG-TERM ASSETS
Property, Plant & Equipment $87.34M $72.59M
YoY Change 20.33% 60.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.62M
YoY Change
Other Assets $1.190M $993.0K
YoY Change 19.84% -41.59%
Total Long-Term Assets $105.2M $73.58M
YoY Change 42.9% 57.23%
TOTAL ASSETS
Total Short-Term Assets $145.3M $137.4M
Total Long-Term Assets $105.2M $73.58M
Total Assets $250.4M $211.0M
YoY Change 18.69% 33.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.705M $15.19M
YoY Change -42.67% 72.56%
Accrued Expenses $15.65M $13.80M
YoY Change 13.44% 43.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $50.95M $53.09M
YoY Change -4.03% 29.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $50.95M $53.09M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $61.46M $62.61M
YoY Change -1.84% 29.35%
SHAREHOLDERS EQUITY
Retained Earnings $35.65M $4.926M
YoY Change 623.75%
Common Stock $153.3M $151.3M
YoY Change 1.31%
Preferred Stock
YoY Change
Treasury Stock (at cost) $7.881M
YoY Change
Treasury Stock Shares 240.0K shares
Shareholders Equity $189.0M $148.4M
YoY Change
Total Liabilities & Shareholders Equity $250.4M $211.0M
YoY Change 18.69% 33.11%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $10.75M $9.241M
YoY Change 16.33% 2.95%
Depreciation, Depletion And Amortization $3.310M $2.710M
YoY Change 22.14% 20.44%
Cash From Operating Activities $14.04M $7.850M
YoY Change 78.85% 35.58%
INVESTING ACTIVITIES
Capital Expenditures $4.974M -$12.53M
YoY Change -139.7% 285.54%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$5.040M -$12.53M
YoY Change -59.78% 285.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.420M -4.430M
YoY Change -67.95% -3.28%
NET CHANGE
Cash From Operating Activities 14.04M 7.850M
Cash From Investing Activities -5.040M -12.53M
Cash From Financing Activities -1.420M -4.430M
Net Change In Cash 7.580M -9.110M
YoY Change -183.21% 346.57%
FREE CASH FLOW
Cash From Operating Activities $14.04M $7.850M
Capital Expenditures $4.974M -$12.53M
Free Cash Flow $9.066M $20.38M
YoY Change -55.52% 125.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.216 pure
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17654113 shares
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
116713000
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17646000 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
50948000
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17646000 shares
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
8705000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
188970000
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
153142000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
35652000
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15651000
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12670000
CY2013Q2 us-gaap Liabilities
Liabilities
61455000
CY2013Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
782000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
176000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
250425000
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
10507000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1190000
CY2013Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4725000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8023000
CY2013Q2 us-gaap Equity Method Investments
EquityMethodInvestments
10618000
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4409000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87344000
CY2013Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
6000000
CY2013Q2 us-gaap Assets
Assets
250425000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
128116000
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
6400000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
145273000
CY2013Q2 apei Deferred Revenue And Student Deposits
DeferredRevenueAndStudentDeposits
25810000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119006000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17752000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17752000 shares
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
55070000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
17251000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
171153000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
157449000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13526000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12042000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11106000
CY2012Q4 us-gaap Liabilities
Liabilities
66450000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
178000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
237603000
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
11380000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1025000
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4290000
CY2012Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4953000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10428000
CY2012Q4 us-gaap Equity Method Investments
EquityMethodInvestments
6664000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6502000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82840000
CY2012Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
6000000
CY2012Q4 us-gaap Assets
Assets
237603000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114901000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
141074000
CY2012Q4 apei Deferred Revenue And Student Deposits
DeferredRevenueAndStudentDeposits
25777000
dei Trading Symbol
TradingSymbol
APEI
dei Entity Registrant Name
EntityRegistrantName
AMERICAN PUBLIC EDUCATION INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001201792
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Basis Of Accounting
BasisOfAccounting
<div><strong><font size="2">2. Basis of Presentation</font></strong> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#xA0;</font></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (&#x201C;GAAP&#x201D;).&#xA0;&#xA0;All intercompany transactions have been eliminated in consolidation.&#xA0;&#xA0;The financial statements do not include all of the information and footnotes required by GAAP for complete financial statement presentations. In the opinion of management, these statements include all adjustments (consisting of normal recurring adjustments) considered necessary to present a fair statement of our consolidated results of operations, financial position and cash flows. Operating results for any interim period are not necessarily indicative of the results that may be expected for the year ending December&#xA0;31, 2013. This Quarterly Report on Form 10-Q should be read in conjunction with the Company&#x2019;s consolidated financial statements and footnotes in its audited financial statements included in its Annual Report, on Form 10-K, for the year ended December&#xA0;31, 2012.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#xA0;</font></div> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Use of Estimates</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Recent Accounting Pronouncements</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#xA0;</font></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There have been no applicable pronouncements since our last filing.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Investments</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On September 30, 2012, the Company made a $6.8 million or approximately 19.9% investment in preferred stock of NWHW Holdings, Inc. (&#x201C;NWHW Holdings&#x201D;), which in turn acquired New Horizons Worldwide, Inc. ("New Horizons"). New Horizons is a global IT training company operating in approximately 260 locations around the world through franchise arrangements in 41 states and 63 countries. In connection with the investment, APEI is entitled to certain rights, including right to representation on the Board of Directors of NWHW Holdings. The Company recorded the investment at cost and will recognize its share of earnings or losses in the investee in the periods for which they are reported with a corresponding adjustment in the carrying amount of the investment.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 20, 2013, the Company made a $4.0 million investment in preferred stock of Fidelis Education,&#xA0;&#xA0;Inc. (&#x201C;Fidelis Education&#x201D;), representing approximately 21.6% of its fully diluted equity. Fidelis Education is developing a technology platform that would assist working adult students with education advising and career mentoring services as they pursue college degrees.&#xA0; In connection with the investment, APEI is entitled to certain rights, including right to representation on the Board of Directors. The Company recorded the investment at cost and will recognize its share of earnings or losses in the investee in the periods for which they are reported with a corresponding adjustment in the carrying amount of the investment.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Note Receivable</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the Company's minority investment in NWHW Holdings, the Company extended $6.0 million in credit to New Horizons in exchange for a subordinated note. The note matures on September 28, 2018, with monthly interest payments of 5.0% per annum during the first five years of the note and interest payments of 6.0% per annum in the sixth year. We evaluate the loan receivable by analyzing the borrower's creditworthiness, cash flows and financial status, and the condition and estimated value of the collateral. We consider a loan to be impaired when, based upon current information and events, we believe it is probable that we will be unable to collect all amounts due according to the contractual terms of the loan agreement.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block">&#xA0;</div> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold"> Commitments and</font> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Contingencies</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#xA0;</font></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company accrues for costs associated with contingencies including, but not limited to, regulatory compliance and legal matters when such costs are probable and can be reasonably estimated. Liabilities established to provide for contingencies are adjusted as further information develops, circumstances change, or contingencies are resolved. The Company bases these accruals on management&#x2019;s estimate of such costs, which may vary from the ultimate cost and expenses associated with any such contingency.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#xA0;</font></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From time to time, the Company may be involved in litigation in the normal course of its business.&#xA0;&#xA0;The Company is not aware of any pending or threatened litigation matters that, in the opinion of management, will have a material adverse effect on the Company&#x2019;s business, operations, financial condition or cash flows.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#xA0;&#xA0;&#xA0;&#xA0;</font></div> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Concentration</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Approximately 35%&#xA0;&#xA0;and 37% of the Company&#x2019;s revenues for the three- and six-month periods ended June&#xA0;30, 2013 were derived from students who received tuition assistance from tuition assistance programs sponsored by the United States Department of Defense (&#x201C;DoD&#x201D;) compared to approximately 39% of the Company&#x2019;s revenues for each of the three- and six-month periods ended June&#xA0;30, 2012.&#xA0;&#xA0;Approximately 17%&#xA0;and 16% of the Company&#x2019;s revenues for the three- and six-month periods ended June&#xA0;30, 2013 were derived from students who were eligible for veterans benefits, compared to approximately 13% of the Company&#x2019;s revenues for each of the three- and six-month periods ended June&#xA0;30, 2012. Approximately 36% and 35% of the Company&#x2019;s revenues for the three and six months ended June&#xA0;30, 2013, were from students using financial aid under the Title IV programs compared to 34% for each of the three= and six-month periods ended June&#xA0;30, 2012. A reduction in any of these programs or a change in maximum benefits allowed to students thereunder could have a significant impact on the Company&#x2019;s operations.</font></div> </div>
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.23
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17948356 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34640000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17704678 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10921000
us-gaap Income Taxes Paid
IncomeTaxesPaid
6228000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-4953000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
163000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
4000000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
164765000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
35566000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-841000
us-gaap Investment Income Net
InvestmentIncomeNet
-46000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
153000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
599000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-46000
us-gaap Operating Income Loss
OperatingIncomeLoss
35413000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-60000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7794000
us-gaap Net Income Loss
NetIncomeLoss
22126000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
785000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1220000
us-gaap Costs And Expenses
CostsAndExpenses
129352000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34637000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6341000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6519000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
13215000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
32584000
us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
33000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13394000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1198000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3609000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
782000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8546000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1243000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
210000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1983000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15084000
apei Share Based Compensation Excluding Director Incentive Shares
ShareBasedCompensationExcludingDirectorIncentiveShares
1983000
apei Other Stock Based Compensation Expense
OtherStockBasedCompensationExpense
49000
apei Instructional Costs And Expenses
InstructionalCostsAndExpenses
55612000
apei Increase Decrease In Allowance For Doubtful Accounts
IncreaseDecreaseInAllowanceForDoubtfulAccounts
1564000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.01
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18182382 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22698000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17881865 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18948000
us-gaap Income Taxes Paid
IncomeTaxesPaid
10401000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
175000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
272000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
150394000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
29849000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2968000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-13000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-474000
us-gaap Operating Income Loss
OperatingIncomeLoss
29862000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8337000
us-gaap Net Income Loss
NetIncomeLoss
18324000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
764000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-423000
us-gaap Costs And Expenses
CostsAndExpenses
120532000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32213000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5771000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5371000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2293000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28846000
us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
-1780000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11525000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1166000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-689000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1133000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
845000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1721000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1930000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19220000
apei Share Based Compensation Excluding Director Incentive Shares
ShareBasedCompensationExcludingDirectorIncentiveShares
1930000
apei Other Stock Based Compensation Expense
OtherStockBasedCompensationExpense
63000
apei Instructional Costs And Expenses
InstructionalCostsAndExpenses
54102000
apei Increase Decrease In Allowance For Doubtful Accounts
IncreaseDecreaseInAllowanceForDoubtfulAccounts
3704000
CY2013Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
4000000
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18151491 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17910787 shares
CY2012Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
74572000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14958000
CY2012Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-34000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
14992000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
9241000
CY2012Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
363000
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
59580000
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16141000
CY2012Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2715000
CY2012Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14475000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5717000
CY2012Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
554000
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
917000
CY2012Q2 apei Instructional Costs And Expenses
InstructionalCostsAndExpenses
26249000
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17835623 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17645682 shares
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
80925000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17291000
CY2013Q2 us-gaap Investment Income Net
InvestmentIncomeNet
2000
CY2013Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
88000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
17203000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
10750000
CY2013Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
383000
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
63722000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17158000
CY2013Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3312000
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16045000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6543000
CY2013Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
585000
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
968000
CY2013Q2 apei Instructional Costs And Expenses
InstructionalCostsAndExpenses
27207000

Files In Submission

Name View Source Status
0001157523-13-003978-index-headers.html Edgar Link pending
0001157523-13-003978-index.html Edgar Link pending
0001157523-13-003978.txt Edgar Link pending
0001157523-13-003978-xbrl.zip Edgar Link pending
a50685425.htm Edgar Link pending
a50685425ex31_01.htm Edgar Link pending
a50685425ex31_02.htm Edgar Link pending
a50685425ex32_01.htm Edgar Link pending
apei-20130630.xml Edgar Link completed
apei-20130630.xsd Edgar Link pending
apei-20130630_cal.xml Edgar Link unprocessable
apei-20130630_def.xml Edgar Link unprocessable
apei-20130630_lab.xml Edgar Link unprocessable
apei-20130630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending